Literature DB >> 33671616

The Impact of Selected Bacterial Sexually Transmitted Diseases on Pregnancy and Female Fertility.

Katarzyna Smolarczyk1, Beata Mlynarczyk-Bonikowska1, Ewa Rudnicka2, Dariusz Szukiewicz3, Blazej Meczekalski4, Roman Smolarczyk2, Wojciech Pieta2.   

Abstract

Sexually transmitted infections (STIs) caused by Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium are a common cause of pelvic inflammatory disease (PID) which can lead to tubal factor infertility (TFI). TFI is one of the most common causes of infertility, accounting for 30% of female fertility problems. STIs can also have an impact on pregnancy, leading to adverse pregnancy outcomes. Escalating antibiotic resistance in Neisseria gonorrhoeae and Mycoplasma genitalium represents a significant problem and can be therapeutically challenging. We present a comprehensive review of the current treatment options, as well as the molecular approach to this subject. We have given special attention to molecular epidemiology, molecular diagnostics, current and new treatments, and drug resistance.

Entities:  

Keywords:  STI; fertility; genotyping; pregnancy; resistance mechanisms

Mesh:

Substances:

Year:  2021        PMID: 33671616      PMCID: PMC7926516          DOI: 10.3390/ijms22042170

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  87 in total

1.  Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau.

Authors:  A-C Labbé; E Frost; S Deslandes; A P Mendonça; A C Alves; J Pépin
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

2.  Tetracycline resistance of Neisseria gonorrhoeae in Russia, 2015-2017.

Authors:  Boris Shaskolskiy; Ekaterina Dementieva; Arvo Leinsoo; Natalia Petrova; Alexander Chestkov; Alexey Kubanov; Dmitry Deryabin; Dmitry Gryadunov
Journal:  Infect Genet Evol       Date:  2018-06-05       Impact factor: 3.342

3.  Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4.

Authors:  Ozlem Equils; Daning Lu; Mary Gatter; Steve S Witkin; Cristina Bertolotto; Moshe Arditi; James A McGregor; Charles F Simmons; Calvin J Hobel
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 4.  Opportunities and pitfalls of molecular testing for detecting sexually transmitted pathogens.

Authors:  Ella Trembizki; Anna-Maria G Costa; Sepehr N Tabrizi; David M Whiley; Jimmy Twin
Journal:  Pathology       Date:  2015-04       Impact factor: 5.306

5.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-03-14

6.  Preterm premature rupture of the membranes and genital mycoplasmas.

Authors:  Marian Kacerovský; Michal Pavlovský; Jindrich Tosner
Journal:  Acta Medica (Hradec Kralove)       Date:  2009

Review 7.  Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs.

Authors:  Tomislav Mestrovic; Suncanica Ljubin-Sternak
Journal:  Front Biosci (Landmark Ed)       Date:  2018-01-01

8.  Association of Mycoplasma genitalium with infertility in North Indian women.

Authors:  Nonika Rajkumari; Harsimran Kaur; Amit Roy; Nalini Gupta; Lakhbir Kaur Dhaliwal; Sunil Sethi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jul-Dec

Review 9.  Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.

Authors:  Beata Młynarczyk-Bonikowska; Anna Majewska; Magdalena Malejczyk; Grażyna Młynarczyk; Sławomir Majewski
Journal:  Med Microbiol Immunol       Date:  2019-12-04       Impact factor: 3.402

10.  MgpB Types among Mycoplasma genitalium Strains from Men Who Have Sex with Men in Berlin, Germany, 2016-2018.

Authors:  Roger Dumke; Marcos Rust; Tobias Glaunsinger
Journal:  Pathogens       Date:  2019-12-20
View more
  8 in total

Review 1.  Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review.

Authors:  Dongmei Wang; Yue Jiang; Jiaxing Feng; Jingshu Gao; Jinlan Yu; Jing Zhao; Pihong Liu; Yaguang Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.629

2.  Copan Walk Away Specimen Processor (WASP) Automated System for Pathogen Detection in Female Reproductive Tract Specimens.

Authors:  Jing Gao; Qiujing Chen; Yiqian Peng; Nanyan Jiang; Youhao Shi; Chunmei Ying
Journal:  Front Cell Infect Microbiol       Date:  2021-11-17       Impact factor: 5.293

Review 3.  Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex).

Authors:  Lucian G Scurtu; Viorel Jinga; Olga Simionescu
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

4.  Evaluation of the Predictive Value of Urine Leukocyte Esterase Test in Chlamydia trachomatis and Neisseria gonorrhoeae Infection Among Males Attending HIV/STI Clinics in Guangdong Province, China.

Authors:  Xueying Yu; Peizhen Zhao; Zhida Mai; Qingqing Xu; Wentao Chen; Zhiqiao Wu; Xiaojuan Luo; Zhizhou Wu; Xiaofeng Liu; Qian Wu; Heping Zheng; Yaohua Xue
Journal:  Front Med (Lausanne)       Date:  2022-03-21

5.  Reproductive Immunology and Pregnancy.

Authors:  Dariusz Szukiewicz
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 6.  Sexually transmitted infections and female reproductive health.

Authors:  Olivia T Van Gerwen; Christina A Muzny; Jeanne M Marrazzo
Journal:  Nat Microbiol       Date:  2022-08-02       Impact factor: 30.964

7.  MiR-378b Modulates Chlamydia-Induced Upper Genital Tract Pathology.

Authors:  Stephanie R Lundy; Kobe Abney; Debra Ellerson; Joseph U Igietseme; Darin Carroll; Francis O Eko; Yusuf O Omosun
Journal:  Pathogens       Date:  2021-05-07

8.  Liposomal Encapsulation Increases the Efficacy of Azithromycin against Chlamydia trachomatis.

Authors:  Anita Bogdanov; László Janovák; Jasmina Vraneš; Tomislav Meštrović; Sunčanica Ljubin-Sternak; Zsuzsanna Cseh; Valéria Endrész; Katalin Burián; Željka Vanić; Dezső P Virok
Journal:  Pharmaceutics       Date:  2021-12-24       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.